Energetic costs of cellular and therapeutic control of stochastic mitochondrial DNA populations
Hanne Hoitzing, Payam A Gammage, Lindsey van Haute, Michal Minczuk, Iain G Johnston, Nick S Jones
(Hanne's also written a post about this paper, you can read it here)
Our cells are filled
with populations of mitochondrial DNA (mtDNA) molecules, which encode
vital cellular machinery that supports our energy requirements. The
cell invests energy in maintaining its mtDNA population, like us
using electricity-powered tools to help maintain our power stations.
Our cellular power stations can vary in quality (for example,
mutations can damage mtDNA), and are subject to random influences.
How should the cell best invest energy in controlling and maintaining
its power stations? And can we use this answer to design better
therapies to address damaged mtDNA?
In a new paper here in
PLoS Computational Biology, we attempt to answer this question using
mathematical modelling, linking with genetic experiments done by our
excellent collaborators at Cambridge (Payam Gammage, Lindsey Van Haute and Michal Minczuk). We first expand a mathematical
model for how diverse mtDNA populations within cells change over time
– building new power stations and decommissioning old ones, under
the “governance” of the cell. We then produce an “energy
budget” for the cellular “society” – describing the costs of
building, decommissioning, and maintaining different power stations,
and the corresponding profits of energy generation.
We find some
surprising results. First, it can get harder to maintain a good
energy budget in a tissue (a collection of individual cellular
“societies”) over time, even if demands stay the same and average
mtDNA quality doesn’t change. This is because the cell-to-cell
variability in mtDNA quality does increase, carrying with it an added
energetic challenge. This increased challenge could be a contributing
factor to the collection of problems involved in ageing.
An overview of our approach. A mathematical model for the processes and "budget" involved in controlling mtDNA populations makes a general set of biological predictions and explains gene-therapy observations
Next, we found that
cells with only low-quality mtDNA can perform worse than cells with a
mix of low- and high-quality mtDNA. This is because low-quality mtDNA
may consume less cellular resource, although global efficiency is
decreased. Linked to this, removal of low-quality mtDNA
(decommissioning bad power stations) alone is not always the best
strategy to improve performance. Instead, jointly elevating low- and
high-quality mtDNA levels, avoiding this detrimental mixed regime, is
the best strategy for some situations. These insights may help
explain some of the negative effects recently observed in cells with
mixed mtDNA populations.
Our theory suggests that mixed mtDNA populations may do worse than pure ones, even if the pure population is a low-functionality mutant. Image from Hanne's post here
We identified how best to control cellular mtDNA populations across the
full range of possible populations, and used this insight to link with
exciting gene therapies where low-quality mtDNA is preferentially
removed through an experimental intervention (using so-called
“endonucleases” to cut particular mtDNA molecules). We found that
strong, single treatments will be outperformed by weaker, longer-term
treatments, and identified how the mtDNA variability we know is present
can practically effect the outcome of these therapies. We hope that the
principles found in this work both add to our basic understanding of
ageing and mixed (“heteroplasmic”) mitochondrial populations, and may
inform more efficient therapeutic approaches in the future. Iain, Hanne, Nick